Inspire Investing LLC Has $665,000 Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Inspire Investing LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 71.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,932 shares of the company's stock after selling 17,095 shares during the quarter. Inspire Investing LLC's holdings in HealthEquity were worth $665,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Janney Montgomery Scott LLC raised its position in shares of HealthEquity by 8.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company's stock valued at $514,000 after buying an additional 420 shares during the last quarter. Nisa Investment Advisors LLC raised its holdings in HealthEquity by 8.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 3,719 shares of the company's stock valued at $357,000 after acquiring an additional 299 shares in the last quarter. Sheets Smith Wealth Management raised its holdings in HealthEquity by 3.5% in the 4th quarter. Sheets Smith Wealth Management now owns 7,965 shares of the company's stock valued at $764,000 after acquiring an additional 273 shares in the last quarter. Atomi Financial Group Inc. increased its position in shares of HealthEquity by 39.8% during the fourth quarter. Atomi Financial Group Inc. now owns 3,553 shares of the company's stock valued at $341,000 after purchasing an additional 1,012 shares during the period. Finally, Chesley Taft & Associates LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at $837,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 2.1 %

NASDAQ:HQY traded up $2.17 on Friday, reaching $106.88. The company's stock had a trading volume of 654,597 shares, compared to its average volume of 607,718. The firm has a market cap of $9.26 billion, a PE ratio of 98.06, a PEG ratio of 1.86 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business's 50-day moving average price is $99.60 and its two-hundred day moving average price is $87.39. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $107.87.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the firm posted $0.40 earnings per share. Equities research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now owns 3,784 shares in the company, valued at $363,642.40. This represents a 21.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,289 shares of company stock valued at $3,355,718 over the last 90 days. 2.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent research reports. Mizuho assumed coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price objective on the stock. Barrington Research boosted their price target on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Monday, December 2nd. Bank of America increased their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research note on Wednesday, November 13th. JMP Securities boosted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.